OVERVIEW

Evidence-Based Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation is organized by Pri-Med and will be held from Jul 13, 2018 - Nov 15, 2019. This CME Conference has been approved for a maximum of 1.50 AMA PRA Category 1 Credits.

Overview :
This activity will provide an evidence-based approach to diagnosing irritable bowel syndrome (IBS) with minimal testing. Diagnostic tests that facilitate a positive diagnosis of IBS and effective approaches for educating patients will be highlighted. The speakers will spotlight diet changes and over-the-counter agents which are helpful first-line therapies. Evidence-based guidelines will identify the most effective and best tolerated prescription agents for IBS and chronic constipation patients.

Learning Objectives :
• Recognize typical symptoms of IBS and CIC and differentiate them from other common GI disorders
• Identify patients with suspected IBS/CIC with alarm symptoms who require further diagnostic investigation
• Identify lack of utility of most diagnostic testing in patients with suspected IBS/CIC, appropriateness of making a proactive diagnosis based on symptoms, and importance of initiating treatment at an initial visit
• Utilize prescription and over the counter agents to treat patients with IBS and CIC based on demonstrated efficacy, safety, and evidence-based guidelines

Additional details will be posted as soon as they are available.